Larvol Delta - SynActCS002-A-Study-of-the-Safety-Tolerability-and-Efficacy-of-Treatment-With-AP1189-in-Early-RA-Patients-With-Active-Joint-Disease

AP1189 - Action

AP 1102 - Action

http://clinicaltrials.gov/ct2/show/NCT04004429

Jul 2, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next